Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer (Q68012210)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500265%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

title

Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500265%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

main subject

metastatic breast cancer

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500265

2 October 2022

author name string

J. A. Benvenuto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500265

2 October 2022

R. A. Newman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500265

2 October 2022

G. S. Bignami

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500265

2 October 2022

T. J. Raybould

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500265

2 October 2022

M. N. Raber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500265

2 October 2022

L. Esparza

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500265

2 October 2022

R. S. Walters

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500265

2 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1500265

2 October 2022

publication date

1 July 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500265%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

20 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500265%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500265%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500265%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

page(s)

113-117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500265%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00873128

20 September 2019

exact match

0 references

cites work

In vivo effect of didemnin B on two tumors of the rat.

1 reference

12 December 2020

In vitro distribution of diacetyl didemnin B in human blood cells and plasma

1 reference

12 December 2020

Mechanism of action of didemnin B, a depsipeptide from the sea

1 reference

12 December 2020

Antiviral and antitumor compounds from tunicates

1 reference

12 December 2020

Biochemical and cellular effects of didemnins A and B.

1 reference

12 December 2020

Antitumor activity of didemnin B in the human tumor stem cell assay

1 reference

12 December 2020

Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data

1 reference

12 December 2020

Phase I clinical and pharmacokinetic investigation of didemnin B, a cyclic depsipeptide

1 reference

12 December 2020

Inhibition of T-lymphocyte proliferation by the cyclic polypeptide didemnin B: no inhibition of lymphokine stimulation

1 reference

12 December 2020

An enzyme immunoassay for determining plasma concentrations of didemnin B

1 reference

12 December 2020

Didemnin B. The first marine compound entering clinical trials as an antineoplastic agent

1 reference

12 December 2020

Didemnins: Antiviral and Antitumor Depsipeptides from a Caribbean Tunicate

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00873128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500265%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1 reference